These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35812993)

  • 1. Assessment of blinding in randomized controlled trials of antidepressants for depressive disorders 2000-2020: A systematic review and meta-analysis.
    Lin YH; Sahker E; Shinohara K; Horinouchi N; Ito M; Lelliott M; Cipriani A; Tomlinson A; Baethge C; Furukawa TA
    EClinicalMedicine; 2022 Aug; 50():101505. PubMed ID: 35812993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review and meta-analysis of the success of blinding in antidepressant RCTs.
    Scott AJ; Sharpe L; Colagiuri B
    Psychiatry Res; 2022 Jan; 307():114297. PubMed ID: 34861421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies.
    Savović J; Jones H; Altman D; Harris R; Jűni P; Pildal J; Als-Nielsen B; Balk E; Gluud C; Gluud L; Ioannidis J; Schulz K; Beynon R; Welton N; Wood L; Moher D; Deeks J; Sterne J
    Health Technol Assess; 2012 Sep; 16(35):1-82. PubMed ID: 22989478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do randomized clinical trials with inadequate blinding report enhanced placebo effects for intervention groups and nocebo effects for placebo groups?
    Feys F; Bekkering GE; Singh K; Devroey D
    Syst Rev; 2014 Feb; 3():14. PubMed ID: 24555576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of blinding on treatment effect size estimate in randomized controlled trials of oral health interventions.
    Saltaji H; Armijo-Olivo S; Cummings GG; Amin M; da Costa BR; Flores-Mir C
    BMC Med Res Methodol; 2018 May; 18(1):42. PubMed ID: 29776394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(7):1-98. PubMed ID: 23074457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.
    Mikocka-Walus A; Prady SL; Pollok J; Esterman AJ; Gordon AL; Knowles S; Andrews JM
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012680. PubMed ID: 30977111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
    Cipriani A; Furukawa TA; Salanti G; Chaimani A; Atkinson LZ; Ogawa Y; Leucht S; Ruhe HG; Turner EH; Higgins JPT; Egger M; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Tajika A; Ioannidis JPA; Geddes JR
    Lancet; 2018 Apr; 391(10128):1357-1366. PubMed ID: 29477251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing blinding in trials of psychiatric disorders: a meta-analysis based on blinding index.
    Freed B; Assall OP; Panagiotakis G; Bang H; Park JJ; Moroz A; Baethge C
    Psychiatry Res; 2014 Oct; 219(2):241-7. PubMed ID: 24930582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trial-level characteristics associate with treatment effect estimates: a systematic review of meta-epidemiological studies.
    Wang H; Song J; Lin Y; Dai W; Gao Y; Qin L; Chen Y; Tam W; Wu IX; Chung VC
    BMC Med Res Methodol; 2022 Jun; 22(1):171. PubMed ID: 35705904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of blinding on estimates of mortality in randomised clinical trials of intensive care interventions: protocol for a systematic review and meta-analysis.
    Anthon CT; Granholm A; Perner A; Laake JH; Møller MH
    BMJ Open; 2017 Jul; 7(7):e016187. PubMed ID: 28701412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blinding of outcome assessors and its association with outcome in a randomized open-label stroke trial.
    van der Ende NA; Roozenbeek B; Broderick JP; Khatri P; Lingsma HF; Dippel DW
    Int J Stroke; 2023 Jun; 18(5):562-568. PubMed ID: 36169032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Blind Leading the Not-So-Blind: A Meta-Analysis of Blinding in Pharmacological Trials for Chronic Pain.
    Colagiuri B; Sharpe L; Scott A
    J Pain; 2019 May; 20(5):489-500. PubMed ID: 30248448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of blinding on estimated treatment effects in randomised clinical trials: meta-epidemiological study.
    Moustgaard H; Clayton GL; Jones HE; Boutron I; Jørgensen L; Laursen DRT; Olsen MF; Paludan-Müller A; Ravaud P; Savović J; Sterne JAC; Higgins JPT; Hróbjartsson A
    BMJ; 2020 Jan; 368():l6802. PubMed ID: 31964641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adults.
    Machmutow K; Meister R; Jansen A; Kriston L; Watzke B; Härter MC; Liebherz S
    Cochrane Database Syst Rev; 2019 May; 5(5):CD012855. PubMed ID: 31106850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.
    Van Leeuwen E; van Driel ML; Horowitz MA; Kendrick T; Donald M; De Sutter AI; Robertson L; Christiaens T
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013495. PubMed ID: 33886130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reporting of outcomes in orthopaedic randomized trials: does blinding of outcome assessors matter?
    Poolman RW; Struijs PA; Krips R; Sierevelt IN; Marti RK; Farrokhyar F; Bhandari M
    J Bone Joint Surg Am; 2007 Mar; 89(3):550-8. PubMed ID: 17332104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of blinding in randomized controlled trials found results inconsistent and questionable.
    Boutron I; Estellat C; Ravaud P
    J Clin Epidemiol; 2005 Dec; 58(12):1220-6. PubMed ID: 16291465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods of blinding in reports of randomized controlled trials assessing pharmacologic treatments: a systematic review.
    Boutron I; Estellat C; Guittet L; Dechartres A; Sackett DL; Hróbjartsson A; Ravaud P
    PLoS Med; 2006 Oct; 3(10):e425. PubMed ID: 17076559
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.